Sort   by:  
 Page size 
UnknownRandomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).
Not available
S-EPMC4622102 | biostudies-literature
UnknownCALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Not available
S-EPMC6128083 | biostudies-literature
UnknownContinued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.
Not available
S-EPMC6553811 | biostudies-literature
UnknownUS Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Not available
S-EPMC4966513 | biostudies-literature
UnknownActive idiotypic vaccination versus control immunotherapy for follicular lymphoma.
Not available
S-EPMC4039868 | biostudies-literature
UnknownSociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS).
Not available
S-EPMC12451849 | biostudies-literature
UnknownComparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
Not available
S-EPMC9463385 | biostudies-literature
UnknownHuman total, basal and activity energy expenditures are independent of ambient environmental temperature.
Not available
S-EPMC9294192 | biostudies-literature
UnknownInternational Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Not available
S-EPMC5834038 | biostudies-literature
UnknownTargeting DNA Damage Response and Replication Stress in Pancreatic Cancer.
Not available
S-EPMC8167930 | biostudies-literature
Sort   by:  
 Page size